FRNM SCHEDULE 13G/A: SEC filing
Perceptive Advisors LLC and related reporting persons
Filed with the SEC on · accession 0001193125-26-463807
FRNM filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -3.1% by the first close after the filing.
Summary of the filing
Perceptive Advisors LLC and related reporting persons filed an amended Schedule 13G disclosing beneficial ownership of approximately 11.3% of Freenome, Inc.'s common stock, with the Perceptive Life Sciences Master Fund holding 12,518,597 shares and C2 Life Sciences LLC holding 87,456 shares.
Key details
How FRNM stock reacted
Close before
$10.41
Nov 13, 2026
First close after
-3.07%
$10.09
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for FRNM, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for FRNM?
Click hereFrequently asked questions
What did FRNM file with the SEC on Nov 16, 2026?
FRNM filed a SCHEDULE 13G/A (SEC filing). Perceptive Advisors LLC and related reporting persons filed an amended Schedule 13G disclosing beneficial ownership of approximately 11.3% of Freenome, Inc.'s common stock, with the Perceptive Life Sciences Master Fund holding 12,518,597 shares and C2 Life Sciences LLC holding 87,456 shares.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did FRNM stock react to this filing?
FRNM closed at $10.41 before the filing and $10.09 on Nov 16, 2026 (-3.07%).
Other FRNM SEC filings
- SCHEDULE 13G/A · SEC filingNov 16, 2026
- SCHEDULE 13G/A · SEC filingNov 16, 2026
- SCHEDULE 13G/A · SEC filingNov 16, 2026
- SCHEDULE 13G/A · SEC filingNov 16, 2026
- 424B3 · Shelf registrationNov 13, 2026
- 10-Q · SEC filingNov 12, 2026
- 8-K · SEC filingNov 10, 2026
- SCHEDULE 13G/A · SEC filingOct 29, 2026
- 424B3 · Fda approvalOct 20, 2026
- 8-K · Fda approvalOct 20, 2026
Get alerts when FRNM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days